Editorial: CCR5: A receptor at the center stage in infection
Ellwanger J.H. Secchi M. Aliberti J. Vangelista L.
18 October 2022Frontiers Media S.A.
Frontiers in Immunology
2022#13
CCR5 , CCR5Δ32 , COVID-19 , gene-editing , HIV therapy , infection , leronlimab , maraviroc
Text of the article Перейти на текст статьи
Laboratory of Immunobiology and Immunogenetics, Department of Genetics, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
Institute of Molecular Genetics, National Research Council, Pavia, Italy
Office of AIDS Research, National Institutes of Health (NIH OAR), Bethesda, MD, United States
Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, Kazakhstan
Laboratory of Immunobiology and Immunogenetics
Institute of Molecular Genetics
Office of AIDS Research
Department of Biomedical Sciences
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026